ALSA Ventures is a life science venture capital investor, focused on early stage novel therapeutics. With a strong operations background in drug development, our team seeks to bring together outstanding entrepreneurs and world class academic researchers to help bring promising new treatments to market. We invest across a wide spectrum of therapeutic areas, targeting high unmet need with impactful outcomes for patients and society at large.
| Website | http://www.alsaventures.com |
| Employees | 10 (6 on RocketReach) |
| Founded | 2019 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+13 more
(view full list)
|
| Industry | Venture Capital and Private Equity Principals |
| Keywords | Venture Capital, Venture Fund, Biotech Venture Capital, Investment, Therapeutics, Early Stage Investing, Capital, Drug Development, Novel Therapeutics, Biotechnology, Pharmaceutical Investing, Healthcare Investing, Seed Funding, Series A Investing, Biotech Investments, Pharmaceutical, Medical Technology, Biopharma |
| Competitors | Techstars, Andreessen Horowitz, Sequoia Capital, Y Combinator, Bessemer Venture Partners, Accel in India, 500 Southeast Asia, Kleiner Perkins, Greylock, Foundry Investments Llc +41 more (view full list) |
Looking for a particular ALSA Ventures employee's phone or email?
Alek Safarian is the CEO of ALSA Ventures.
6 people are employed at ALSA Ventures.